CERS:NASDAQ
Cerus Corp
$2.30
arrow_upward
+0.88%(+0.020) 1D
$2.30
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 9, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CERS...
Open
$2.31
High
$2.33
Low
$2.27
Mkt. cap
463.51M
Avg. vol.
1.65M
Volume
787.97K
52-wk high
$3.47
52-wk low
$1.38
EPS
-$0.03
Beta
1.83
Shares outstanding
201.52M
No. of employees
268
Open
$2.31
High
$2.33
Low
$2.27
Mkt. cap
463.51M
Avg. vol.
1.65M
Volume
787.97K
52-wk high
$3.47
52-wk low
$1.38
EPS
-$0.03
Beta
1.83
Shares outstanding
201.52M
No. of employees
268
News stories
From web sources and news partners
FXLeaders
·
1 hour ago
Dow Jones and Nasdaq Futures Start Higher Ahead of US Inflation Data
CryptoRank
·
9 hours ago
Pokémon Cards Just Crushed Bitcoin, Gold and the S&P 500 With 150% Returns
Hindustan Times
·
5 hours ago
Why are 54% of US stocks down 20% as the S&P 500 nears a record high? | Hindustan Times
Traders Union
·
3 hours ago
Yuriy Matso: S&P500 negative beta to SPY at record 18.9 percent
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
FoundedSep 1991
HeadquartersConcord, California, United States
SectorMedical device
Websitecerus.com